comparemela.com

Latest Breaking News On - Spero therapeutic - Page 1 : comparemela.com

Head to Head Survey: Coya Therapeutics (NASDAQ:COYA) vs Spero Therapeutics (NASDAQ:SPRO)

Coya Therapeutics (NASDAQ:COYA – Get Free Report) and Spero Therapeutics (NASDAQ:SPRO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Volatility and Risk Coya Therapeutics has a […]

Spero Therapeutics, Inc (NASDAQ:SPRO): Are Analysts Optimistic?

We feel now is a pretty good time to analyse Spero Therapeutics, Inc.'s ( NASDAQ:SPRO ) business as it appears the.

Cantor Fitzgerald Reaffirms Overweight Rating for Spero Therapeutics (NASDAQ:SPRO)

Cantor Fitzgerald reissued their overweight rating on shares of Spero Therapeutics (NASDAQ:SPRO – Free Report) in a report published on Monday morning, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Spero Therapeutics’ FY2024 earnings at ($0.85) EPS. Separately, HC Wainwright restated a buy rating and set a $7.00 price objective on shares of Spero Therapeutics […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.